Drugmakers: High Court Must Hear Class Certification Case To Resolve Circuit Split

( February 19, 2026, 9:29 AM EST) -- WASHINGTON, D.C. — Two drug companies on Feb. 18 told the U.S. Supreme Court that opposition to their petition for a writ of certiorari filed by Painters and Allied Trades District Council 82 Health Care Fund is “revisionist history in the extreme” and that the court should hear the case to resolve whether the Ninth Circuit U.S. Court of Appeals erred in certifying a national third-party payer (TPP) class of entities that paid for the diabetes drug Actos....